Companies / Hyku Biosciences
Hyku Biosciences
Burlington, United States
Hyku Biosciences is developing small molecule therapeutics with novel mechanisms of action to potently inactivate proteins that drive disease progression.
Hyku Biosciences, based in Burlington, United States, has 5 investors on file, among them Chugai Venture Fund, Droia Ventures and Eisai Innovation Inc.. Its latest round on record is Series A, 30 Jul 2026. Its site was last checked 13 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
5 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Corporate VC | |
| Portfolio page | Venture capital | |
| Portfolio page | Corporate VC | |
| Portfolio page | Corporate VC | |
| Portfolio page | Investor |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Hyku Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Chugai Venture Fund adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/hykubiosciences.com/investors
# also
GET /v1/companies/hykubiosciences.com
GET /v1/companies/hykubiosciences.com/news